Joseph Payne

Joseph Payne, is co-founder, CEO, and chairman of San Diego-based Arcturus Therapeutics, which is advancing proprietary technology for developing RNAi-based drugs targeting orphan diseases. He has over 20 years of successfully drug discovery experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto Denko. He has over 40 publications and patents and seven investigational new drug candidates.

His academic training includes Brigham Young University (magna cum laude, Chemistry and Physics), University of Calgary (Synthetic Organic Chemistry), and MIT Sloan School of Management (Executive Training, Supply Chain and Logistics Strategy).

Page 1 of 1